DAPL1 rs17810398: Vision and Macular Degeneration
The genetic variant rs17810398 is a common single nucleotide polymorphism located in the DAPL1 gene. Scientific research has linked this variant to altered susceptibility to age-related macular degeneration (AMD), demonstrating notable sex-stratified effects where risk associations appear primarily among females. However, overall evidence for rs17810398 acting as a direct causal driver remains limited, with researchers proposing it may tag nearby regulatory variants.
What each genotype means
Baseline AMD risk
You carry two copies of the C allele at rs17810398, which corresponds to the standard non-risk reference genotype in published research. Published studies indicate this genotype is not associated with the increased risk of age-related macular degeneration (AMD) identified for alternate allele carriers. Research shows this locus primarily exhibits sex-stratified effects, but overall evidence for this candidate gene association remains limited.
Carried by approximately 30% to 42% of individuals globally, varying by ancestry.
Moderately altered AMD susceptibility
You carry one copy of the T allele at rs17810398. Candidate gene studies suggest this allele is associated with increased susceptibility to age-related macular degeneration (AMD), predominantly displaying an effect in biological females while showing minimal to no detectable risk shift in males. Because this finding stems from candidate gene studies with limited overall evidence, it should be regarded with caution rather than as a definitive diagnostic risk factor.
Carried by approximately 45% to 50% of individuals across global populations.
Altered AMD susceptibility
You carry two copies of the T risk allele at rs17810398 in the DAPL1 gene. Clinical research has associated the T allele with a higher susceptibility to age-related macular degeneration (AMD), with associations showing notable sex-specific divergence where risk is primarily elevated in biological females. Overall scientific evidence for this locus remains limited and is not currently used for standalone clinical risk prediction.
Carried by approximately 12% to 20% of individuals worldwide.
Understanding rs17810398 and the DAPL1 Locus
The single nucleotide polymorphism rs17810398 is situated on chromosome 2 within the death-associated protein-like 1 (DAPL1) gene. At the molecular level, it represents a synonymous coding variant, meaning that a base transition between cytosine (C) and thymine (T) does not alter the underlying amino acid sequence of the encoded protein. Because synonymous changes do not alter protein structure directly, researchers often investigate them as genetic markers that are co-inherited with functional non-coding variants. At the DAPL1 locus, rs17810398 exists in high linkage disequilibrium with other nearby single nucleotide changes and structural variations. Genomic fine-mapping suggests that rather than acting alone, rs17810398 tracks a haplotype involved in modulating DAPL1 transcript levels. Consequently, it serves primarily as an informative genetic tag for biological activity within this specific genomic region.
Biological Function of the DAPL1 Gene in the Eye
DAPL1 encodes death-associated protein-like 1, a protein with prominent expression in epithelial and ocular tissues, especially the retinal pigment epithelium (RPE) and neurosensory retina. The RPE forms a vital barrier that nourishes photoreceptors, processes visual cycle intermediates, and clears metabolic waste through autophagy. Laboratory studies in animal and cellular models indicate that DAPL1 acts as a regulator of epithelial cell proliferation, autophagy, and antioxidant defenses. When DAPL1 expression is altered or deficient in experimental models, RPE cells exhibit impaired stress responses, increased cell death pathways such as PANoptosis, and progressive retinal thinning resembling dry macular degeneration. DAPL1 produces multiple alternative splice isoforms in the retina, and genetic variation across this locus appears to influence the balance and abundance of specific transcript isoforms necessary for long-term retinal tissue maintenance.
Research Findings and Sex-Stratified Risk Patterns
Association between rs17810398 and age-related macular degeneration was initially highlighted in targeted candidate-gene and replication studies analyzing thousands of clinical cases and controls. An intriguing finding from these investigations is sex stratification: the association between the minor T allele and increased risk of AMD reached statistical significance in female cohorts, while showing minimal or absent statistical signal in males. Scientists hypothesize that estrogen-receptor signaling or sex-specific differences in RPE cellular turnover might interact with DAPL1 expression, explaining why the female subgroup drove the observed association. Nevertheless, evidence strength remains categorized as limited. While candidate gene studies reported compelling associations, broad unstratified genome-wide association studies (GWAS) often dilute sex-specific signals or highlight other primary loci like CFH and ARMS2/HTRA1, meaning DAPL1's contribution is modest and context-dependent.
Population Frequency and Allelic Distribution
The rs17810398 variant is common across diverse global populations. According to large population genomic databases like gnomAD and dbSNP, the minor T allele exhibits a global frequency typically ranging between 0.35 and 0.45. This high prevalence means that heterozygous and homozygous genotypes are widespread across healthy populations around the world. Because roughly a third or more of individuals in many ancestry groups carry at least one copy of the T allele, carrying the variant does not denote disease. Instead, it reflects standard human genetic variation that exerts subtle statistical influences when combined with lifestyle, age, and other polygenic risk factors.
Clinical Utility and Lifestyle Considerations
Genetic tests reporting rs17810398 provide statistical information rather than a clinical diagnosis. Having one or two copies of the T allele does not mean that an individual will develop age-related macular degeneration, nor does carrying the CC genotype provide absolute immunity. AMD is a multifactorial condition driven strongly by non-genetic factors such as chronological age, cigarette smoking, cardiovascular health, and dietary antioxidant intake, alongside dozens of other genetic loci. Readers learning their DAPL1 genotype cannot use this single marker to dictate medical interventions or disease prognoses. The most effective evidence-based actions for protecting retinal health remain universal: scheduling regular comprehensive dilated eye exams, avoiding tobacco smoke, wearing ultraviolet-protective eyewear outdoors, and maintaining a nutrient-dense diet rich in leafy green vegetables and omega-3 fatty acids.
How common is this variant?
The minor T allele of rs17810398 occurs at a frequency of approximately 0.35 to 0.45 across global populations according to gnomAD data, making both heterozygous and homozygous genotypes common worldwide.
Frequently asked questions
Does carrying the rs17810398 T allele mean I will get macular degeneration?
No. The rs17810398 variant is only associated with a modest statistical shift in susceptibility in observational studies, predominantly in females. Age-related macular degeneration is a multifactorial condition influenced heavily by age, smoking, overall cardiovascular health, and dozens of other genes.
Why is the association with rs17810398 reported mainly in females?
Candidate gene studies identified that statistical associations between rs17810398 and macular degeneration reached significance in female cohorts but not in males. Scientists speculate this could involve interactions between sex hormones, such as estrogen, and the regulation of DAPL1 isoforms in the retinal pigment epithelium.
Is rs17810398 the direct cause of altered retinal function?
Probably not. rs17810398 is a synonymous variant that does not alter any protein amino acids. Experimental tissue studies suggest it is in high linkage disequilibrium with other nearby non-coding or structural variants that directly influence the expression of specific DAPL1 transcript isoforms.
Can eye drops or medications treat the rs17810398 variant?
There are no medical therapies or medications that target or alter the rs17810398 genotype. Standard eye care, including regular comprehensive dilated examinations, UV protection, smoking cessation, and a diet rich in lutein and antioxidants, remains the primary approach for preserving macular health.
Sources & further reading
Educational information only, last refreshed 9/13/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs17810398?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29